Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1000
-0.0100 (-9.09%)
Oct 7, 2026, 4:10 PM AEST

ASX:LDX Revenue

In the fiscal year ending June 30, 2026, Lumos Diagnostics Holdings had annual revenue of $13.19M USD with 6.39% growth. Lumos Diagnostics Holdings had revenue of $7.07M in the half year ending June 30, 2026, a decrease of -15.46%. That makes Lumos Diagnostics Holdings the world's #35,985 largest public company by revenue and #633 in Australia.

Revenue
$13.19M
Revenue Growth
+6.39%
P/S Ratio
4.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
94.48M AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202613.19M792.00K6.39%
Jun 30, 202512.40M1.27M11.40%
Jun 30, 202411.13M596.00K5.66%
Jun 30, 202310.54M-1.10M-9.42%
Jun 30, 202211.63M-7.22M-38.32%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Saluda Medical130.35M
SomnoMed114.53M
Aroa Biosurgery86.47M
Compumedics61.88M
Cyclopharm34.42M
Micro-X15.09M
EBR Systems9.32M
EMVision Medical Devices8.36M
Revenue Rankings